Michael Navitsky1, Abhinay D Joshi1, Ian Kennedy1, William E Klunk2, Christopher C Rowe3, Dean F Wong4, Michael J Pontecorvo1, Mark A Mintun1, Michael D Devous5. 1. Avid Radiopharmaceuticals, Philadelphia, PA, USA. 2. Departments of Neurology and Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 3. Department of Molecular Imaging and Therapy, Austin Health and Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. 4. Radiology, Psychiatry, Neuroscience, Neurology, Environmental Health Sciences, and Carey Business School, Johns Hopkins University, Section of High Resolution Brain PET Imaging, Division of Nuclear Medicine, Baltimore, MD, USA. 5. Avid Radiopharmaceuticals, Philadelphia, PA, USA. Electronic address: devous@avidrp.com.
Abstract
INTRODUCTION: Klunk et al. recently proposed a means of standardizing quantitation of amyloid burden from positron emission tomography scans to a common Centiloid scale, and we have applied that method to florbetapir. METHODS: Florbetapir and Pittsburgh compound B scans were acquired for 46 mixed clinical presentation subjects within 18 ± 20 days. Florbetapir and Pittsburgh compound B cortical standardized uptake value ratio (SUVr) values were well correlated for both standard Centiloid (R2 = 0.894) and Avid (R2 = 0.901) volume of interests (VOIs). The methods of Klunk et al. were applied to establish a conversion first from florbetapir SUVr values obtained using standard Centiloid VOIs to Centiloids and then from Avid VOIs (Joshi et al.) to Centiloids. RESULTS: The equation for conversion of florbetapir SUVr from Avid VOIs to the Centiloid scale was as follows: Florbetapir Centiloids = 183 × SUVrAvid - 177. The threshold that discriminated neuropathologically verified none or sparse versus moderate to frequent plaques in autopsy-confirmed data is 24.1 Centiloids. DISCUSSION: These findings may allow improved tracer-independent amyloid quantitation.
INTRODUCTION: Klunk et al. recently proposed a means of standardizing quantitation of amyloid burden from positron emission tomography scans to a common Centiloid scale, and we have applied that method to florbetapir. METHODS:Florbetapir and Pittsburgh compound B scans were acquired for 46 mixed clinical presentation subjects within 18 ± 20 days. Florbetapir and Pittsburgh compound B cortical standardized uptake value ratio (SUVr) values were well correlated for both standard Centiloid (R2 = 0.894) and Avid (R2 = 0.901) volume of interests (VOIs). The methods of Klunk et al. were applied to establish a conversion first from florbetapir SUVr values obtained using standard Centiloid VOIs to Centiloids and then from Avid VOIs (Joshi et al.) to Centiloids. RESULTS: The equation for conversion of florbetapir SUVr from Avid VOIs to the Centiloid scale was as follows: Florbetapir Centiloids = 183 × SUVrAvid - 177. The threshold that discriminated neuropathologically verified none or sparse versus moderate to frequent plaques in autopsy-confirmed data is 24.1 Centiloids. DISCUSSION: These findings may allow improved tracer-independent amyloid quantitation.
Authors: Jianfeng Wu; Jie Zhang; Qingyang Li; Yi Su; Kewei Chen; Eric M Reiman; Jie Wang; Natasha Lepore; Jieping Ye; Paul M Thompson; Yalin Wang Journal: Proc SPIE Int Soc Opt Eng Date: 2020-11-03
Authors: Eric McDade; Iryna Voytyuk; Paul Aisen; Randall J Bateman; Maria C Carrillo; Bart De Strooper; Christian Haass; Eric M Reiman; Reisa Sperling; Pierre N Tariot; Riqiang Yan; Colin L Masters; Robert Vassar; Stefan F Lichtenthaler Journal: Nat Rev Neurol Date: 2021-09-21 Impact factor: 42.937
Authors: Malgorzata M Michalowska; Karl Herholz; Rainer Hinz; Chinenye Amadi; Lynn McInnes; Jose M Anton-Rodriguez; Thomas K Karikari; Kaj Blennow; Henrik Zetterberg; Nicholas J Ashton; Neil Pendleton; Stephen F Carter Journal: Mol Psychiatry Date: 2022-07-20 Impact factor: 13.437
Authors: Pierrick Bourgeat; Vincent Doré; Samantha C Burnham; Tammie Benzinger; Duygu Tosun; Shenpeng Li; Manu Goyal; Pamela LaMontagne; Liang Jin; Christopher C Rowe; Michael W Weiner; John C Morris; Colin L Masters; Jurgen Fripp; Victor L Villemagne Journal: Neuroimage Date: 2022-07-30 Impact factor: 7.400
Authors: Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust Journal: J Neurosci Date: 2020-11-20 Impact factor: 6.167
Authors: Victor L Villemagne; Frederik Barkhof; Valentina Garibotto; Susan M Landau; Agneta Nordberg; Bart N M van Berckel Journal: Radiology Date: 2021-01-19 Impact factor: 11.105
Authors: Michelle E Farrell; Shu Jiang; Aaron P Schultz; Michael J Properzi; Julie C Price; J Alex Becker; Heidi I L Jacobs; Bernard J Hanseeuw; Dorene M Rentz; Victor L Villemagne; Kathryn V Papp; Elizabeth C Mormino; Rebecca A Betensky; Keith A Johnson; Reisa A Sperling; Rachel F Buckley Journal: Neurology Date: 2020-11-16 Impact factor: 9.910